Anime fans looking for a new psychological thriller have a new option to add to their Monday watchlist. Crunchyroll announced that the English dub of the Liar Game anime adaptation begins streaming ...

Crunchyroll streams Daemons of the Shadow Realm worldwide starting this weekend with a same-day English dub The anime adapts Hiromu Arakawa’s latest manga, blending mystical battles and village ...

Netflix debuts the English‑dubbed trailer for STEEL BALL RUN JoJo’s Bizarre Adventure Premiering March 19, 2026 on Netflix, Episode 1 is a 47‑minute special centering on the “first stage” of the race ...

Gen Z, this will smart. The generation born between 1997 and 2010 is the very first generation who did worse in school than the generation before them, according to a top neuroscientist. And ...

One of the bigger features to hit YouTube over the past couple of years, and the platform has had some large ones, is the brand's AI dubbing feature. This feature automatically adds additional ...

English dub fans can now check out the darkest breakout anime of last year as it has now come to Crunchyroll at last. There are quite a lot of new anime releases for English dub fans with Crunchyroll ...

After a long wait, Jujutsu Kaisen Season 3 has finally premiered with its first two episodes. The premiere was everything that we expected and beyond. Fans were desperately waiting to experience the ...

Daiichi Sankyo and Merck & Co.’s phase 3 program for their investigational antibody-drug conjugate has been hit with a hold after an unexpected number of deaths were reported in the global trial. “Due ...

The FDA has approved trastuzumab deruxtecan (T-DXd; Enhertu, Daiichi Sankyo/AstraZeneca) in combination with pertuzumab for the first-line treatment of unresectable or metastatic HER2-positive breast ...

Patients with human epidermal growth factor receptor 2 (HER2)–positive early breast cancer and residual disease after neoadjuvant therapy are at high risk for recurrence. In a phase 3, open-label, ...

T-DXd significantly improves progression-free and overall survival compared to T-DM1 in HER2-positive metastatic breast cancer, with a favorable safety profile. Real-world data show T-DXd's ...